Bhatt, D.L.

patient disease factor risk factors event study registry group heparin death control polyvascular polyvascular disease heart eptifibatide stroke baseline atherothrombotic treatment table analysis artery artery disease therapy outcome polyvascular disease patients angina heparin discontinuation atherothrombosi event rates atrial fi brillation <0.0001 trial population risk factor control aortic discontinuation surgery aneurysm prevalence month university mortality atherothrombotic disease placebo medicine end point non-fatal syndrome guideline history rebound hospital atrial ischemic hypertension 12 hours follow-up infarction point heparin therapy aortic aneurysm period predictor diabetes pursuit smoking agent /iiia result atherothrombotic risk factors 12- hour period <0.001 level nonfatal mi characteristic elevation increase association ischaemic